New Guidance on AI-Driven Evidence in Health Technology Assessments
The CDA-AMC has issued new guidance recognizing that evidence submitted for health technology assessments will increasingly be informed by artificial intelligence. The agency has clarified its expectations for companies using AI methods in generating and/or reporting evidence. This move acknowledges the growing role of AI in healthcare decision-making and aims to provide clarity on the standards for AI-driven evidence submission.
The guidance is significant as it addresses the evolving landscape of health technology assessments, where AI is playing an increasingly important role. By clarifying its expectations, the CDA-AMC aims to ensure that AI-driven evidence meets the necessary standards for health technology assessments.
